Your steadfast partner on the clinical trial journey
We have the experience, scale and reach to support you successfully from discovery through CDx Development.
We are Sysmex Inostics, a CLIA certified lab based in Baltimore, MD, and a pioneering leader in the liquid biopsy revolution.
Discovery and monitoring
Our broad portfolio of molecular assays yields informative data from cfDNA and cfRNA samples to aid in your therapy development.
Large cfDNA & cfRNA enrichment library to identify novel biomarkers
Investigate the genomic landscape for TMB, HRD and MSI
Utilize tissue-informed solutions for comprehensive variant monitoring
Greater sequencing depth to allow for higher sensitivity and specificity
Tumor agnostic approach optimized for detection of ultra-low frequency mutations
Simplified data analysis and assays designed to meet the needs of clinical intended use
Highly sensitive approach for 1 – 5 targets
Minimal sample prep and faster results (within hours)
Ability to monitor response to treatment or patient stratification
CDx development
We teamed up with QIAGEN to accelerate global CDx development. Our collective expertise allows us to anticipate and understand your specific needs throughout the clinical trial process.
Accelerating the pace of drug discovery & development
As a trusted partner in clinical trial solutions, we are accelerating the pace of drug discovery and development, enabling new treatment alternatives and renewed hope for cancer patients. Let us help you achieve a successful clinical trial.
Supporting biopharma with the clinical trial process
We are fully committed to providing unwavering support to our biopharma clients at every stage of the clinical trial process. Our aim is to deliver seamless end-to-end solutions without any compromises or unnecessary complexities. Our extensive portfolio includes a wide range of cfDNA and cfRNA NGS services, all backed by an exceptional project management team that sets us apart.